• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室辅助装置选择中传动系统特征与传动系统感染之间的相关性

Correlation between driveline features and driveline infection in left ventricular assist device selection.

作者信息

Imamura Teruhiko, Murasawa Takahide, Kawasaki Hironori, Kashiwa Koichi, Kinoshita Osamu, Nawata Kan, Ono Minoru

机构信息

Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Department of Medical Engineering, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

出版信息

J Artif Organs. 2017 Mar;20(1):34-41. doi: 10.1007/s10047-016-0923-8. Epub 2016 Jul 22.

DOI:10.1007/s10047-016-0923-8
PMID:27448017
Abstract

Although the survival rate for left ventricular assist device (LVAD) therapy has improved, device-related complications are an unpredictable threat to the patient's quality of life. We focused on driveline infection, and aimed to determine whether specific features of drivelines affect the frequency of infection. We enrolled patients who underwent LVAD implantation and were followed-up at our institute between 2007 and 2015. We counted the occurrences of driveline infection requiring any antibiotic therapy over a 2-year study period. Furthermore, we experimentally measured and compared the outer diameters and stiffness of three devices. Of all, 72 patients received an LVAD during the enrollment period. LVADs were HeartMate II (n = 32), EVAHEART (n = 22), and DuraHeart (n = 18). The outer diameters and stiffness were measured in five of each device. HeartMate II group had the highest driveline infection-free rate among all three devices during the study period (p = 0.042). The driveline of the HeartMate II LVAD had a significantly smaller outer diameter and lower stiffness than that of the other two devices (p < 0.05 for both). In conclusion, device-specific driveline features may affect the development of driveline infection during LVAD therapy.

摘要

尽管左心室辅助装置(LVAD)治疗的生存率有所提高,但与装置相关的并发症对患者的生活质量构成了不可预测的威胁。我们重点关注了驱动线感染,并旨在确定驱动线的特定特征是否会影响感染频率。我们纳入了2007年至2015年间在我院接受LVAD植入并接受随访的患者。我们统计了在为期2年的研究期间需要任何抗生素治疗的驱动线感染的发生情况。此外,我们通过实验测量并比较了三种装置的外径和硬度。在纳入期间,共有72例患者接受了LVAD治疗。LVAD分别为HeartMate II(n = 32)、EVAHEART(n = 22)和DuraHeart(n = 18)。每种装置各选取5个测量其外径和硬度。在研究期间,HeartMate II组在所有三种装置中的无驱动线感染率最高(p = 0.042)。HeartMate II LVAD的驱动线外径明显小于其他两种装置,硬度也低于其他两种装置(两者p均<0.05)。总之,特定装置的驱动线特征可能会影响LVAD治疗期间驱动线感染的发生。

相似文献

1
Correlation between driveline features and driveline infection in left ventricular assist device selection.左心室辅助装置选择中传动系统特征与传动系统感染之间的相关性
J Artif Organs. 2017 Mar;20(1):34-41. doi: 10.1007/s10047-016-0923-8. Epub 2016 Jul 22.
2
Percutaneous Driveline Fracture After Implantation of the HeartMate II Left Ventricular Assist Device: How Durable is Driveline Repair?植入HeartMate II型左心室辅助装置后经皮驱动线骨折:驱动线修复的耐久性如何?
ASAIO J. 2017 Sep/Oct;63(5):542-545. doi: 10.1097/MAT.0000000000000531.
3
Use of left ventricular assist device (HeartMate II): a Singapore experience.左心室辅助装置(HeartMate II)的应用:新加坡的经验
Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.
4
Risk of left ventricular assist device driveline infection: A systematic literature review.左心室辅助装置驱动线感染的风险:系统文献回顾。
Heart Lung. 2019 Mar-Apr;48(2):90-104. doi: 10.1016/j.hrtlng.2018.11.002. Epub 2018 Dec 17.
5
Device exchange after primary left ventricular assist device implantation: indications and outcomes.初次左心室辅助装置植入后器械更换:适应证和结果。
Ann Thorac Surg. 2013 Apr;95(4):1262-7; discussion 1267-8. doi: 10.1016/j.athoracsur.2012.08.031. Epub 2012 Oct 11.
6
Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.传动系统角度对于预防使用HeartMate II设备的患者发生传动系统感染至关重要。
J Artif Organs. 2019 Mar;22(1):37-43. doi: 10.1007/s10047-018-1074-x. Epub 2018 Oct 8.
7
Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.左心室辅助装置植入术后驱动线出口部位的特殊处理与伤口护理
Thorac Cardiovasc Surg. 2015 Dec;63(8):670-4. doi: 10.1055/s-0035-1554961. Epub 2015 Jul 15.
8
Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection.需要手术治疗的严重左心室辅助装置相关感染:发病率、预测因素、对生存的影响及装置选择的作用
J Card Surg. 2019 Feb;34(2):82-91. doi: 10.1111/jocs.13987. Epub 2019 Feb 2.
9
The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.与HeartMate左心室辅助装置相比,Jarvik 2000引发的感染较少。
Eur J Cardiothorac Surg. 2003 May;23(5):748-54; discussion 754-5. doi: 10.1016/s1010-7940(03)00073-3.
10
Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series.负压伤口疗法治疗 HeartMate III-LVAD 移植物感染:我们的病例系列研究结果。
Int J Artif Organs. 2021 Nov;44(11):912-916. doi: 10.1177/03913988211047250. Epub 2021 Sep 24.

引用本文的文献

1
Heartware ventricular assist device versus HeartMate II versus HeartMate III in advanced heart failure patients: A systematic review and meta-analysis.心力衰竭晚期患者使用Heartware心室辅助装置与HeartMate II及HeartMate III的比较:一项系统评价与荟萃分析
SAGE Open Med. 2024 Aug 30;12:20503121241278226. doi: 10.1177/20503121241278226. eCollection 2024.
2
Anti-infective characteristics of a new Carbothane ventricular assist device driveline.新型卡波硫醚心室辅助装置传动系统的抗感染特性
Biofilm. 2023 Apr 17;5:100124. doi: 10.1016/j.bioflm.2023.100124. eCollection 2023 Dec.
3
Decreasing driveline infections in patients supported on ventricular assist devices: a care pathway approach.

本文引用的文献

1
Left ventricular assist device driveline infections: recent advances and future goals.左心室辅助装置驱动线感染:最新进展与未来目标
J Thorac Dis. 2015 Dec;7(12):2151-7. doi: 10.3978/j.issn.2072-1439.2015.11.06.
2
Rectus-Sparing Technique for Driveline Insertion of Ventricular Assist Device.心室辅助装置驱动线插入的保留直肌技术
Ann Thorac Surg. 2015 Nov;100(5):1920-2. doi: 10.1016/j.athoracsur.2015.02.138.
3
Seventh INTERMACS annual report: 15,000 patients and counting.国际机械循环辅助装置注册研究(INTERMACS)第七年度报告:15000例患者及仍在增加。
降低心室辅助装置支持患者的导管相关感染:一种护理途径方法。
BMJ Open Qual. 2022 May;11(2). doi: 10.1136/bmjoq-2022-001815.
4
Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests.驱动线特征作为左心室辅助装置感染的危险因素:荟萃分析与实验测试
Front Cardiovasc Med. 2021 Dec 16;8:784208. doi: 10.3389/fcvm.2021.784208. eCollection 2021.
5
On the function of biosynthesized cellulose as barrier against bacterial colonization of VAD drivelines.生物合成纤维素作为防止 VAD 导管定植细菌的屏障的功能。
Sci Rep. 2021 Sep 21;11(1):18776. doi: 10.1038/s41598-021-98220-4.
6
Systems of conductive skin for power transfer in clinical applications.用于临床应用中的能量传递的导电皮肤系统。
Eur Biophys J. 2022 Mar;51(2):171-184. doi: 10.1007/s00249-021-01568-8. Epub 2021 Sep 3.
7
Ventricular Assist Device-Specific Infections.心室辅助装置相关感染
J Clin Med. 2021 Jan 25;10(3):453. doi: 10.3390/jcm10030453.
8
Left ventricular assist device driveline infections in three contemporary devices.三种当代心室辅助装置的驱动轴感染。
Artif Organs. 2021 May;45(5):464-472. doi: 10.1111/aor.13843. Epub 2020 Nov 28.
9
In Full Flow: Left Ventricular Assist Device Infections in the Modern Era.全面解析:现代左心室辅助装置感染
Open Forum Infect Dis. 2020 Apr 17;7(5):ofaa124. doi: 10.1093/ofid/ofaa124. eCollection 2020 May.
10
Significant impact of left ventricular assist device models on the value of flow-mediated dilation: effects of LVAD on endothelial function.左心室辅助装置模型对血流介导的血管舒张值的显著影响:左心室辅助装置对内皮功能的影响
Heart Vessels. 2020 Feb;35(2):207-213. doi: 10.1007/s00380-019-01474-2. Epub 2019 Jul 20.
J Heart Lung Transplant. 2015 Dec;34(12):1495-504. doi: 10.1016/j.healun.2015.10.003. Epub 2015 Oct 8.
4
Left Ventricular Assist Device Driveline Infections: The Achilles' Heel of Destination Therapy.左心室辅助装置驱动线感染:目标治疗的致命弱点。
AACN Adv Crit Care. 2015 Oct-Dec;26(4):300-5. doi: 10.1097/NCI.0000000000000108.
5
Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.左心室辅助装置植入术后驱动线出口部位的特殊处理与伤口护理
Thorac Cardiovasc Surg. 2015 Dec;63(8):670-4. doi: 10.1055/s-0035-1554961. Epub 2015 Jul 15.
6
Advantage of Pulsatility in Left Ventricular Reverse Remodeling and Aortic Insufficiency Prevention During Left Ventricular Assist Device Treatment.左心室辅助装置治疗期间搏动性在左心室逆向重构和预防主动脉瓣关闭不全中的优势
Circ J. 2015;79(9):1994-9. doi: 10.1253/circj.CJ-15-0419. Epub 2015 Jun 25.
7
Readmissions After Continuous Flow Left Ventricular Assist Device Implantation: Differences Observed Between Two Contemporary Device Types.连续血流左心室辅助装置植入后的再入院情况:两种当代装置类型之间的差异观察
ASAIO J. 2015 Jul-Aug;61(4):410-6. doi: 10.1097/MAT.0000000000000218.
8
A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management.左心室辅助装置患者感染的综述:预防、诊断与管理
Methodist Debakey Cardiovasc J. 2015 Jan-Mar;11(1):28-32. doi: 10.14797/mdcj-11-1-28.
9
Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry.降低动力轴感染率:来自 HeartMate II 多中心动力轴硅胶皮肤界面(SSI)登记研究的结果。
J Heart Lung Transplant. 2015 Jun;34(6):781-9. doi: 10.1016/j.healun.2014.11.021. Epub 2014 Dec 5.
10
Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.在长期左心室辅助装置支持期间,通过使用血清白蛋白和体重指数的新评分可以预测因驱动线感染导致的再次入院情况。
J Artif Organs. 2015 Jun;18(2):120-7. doi: 10.1007/s10047-015-0816-2. Epub 2015 Jan 21.